middle.news
Mesoblast’s Ryoncil launch opens a new chapter beyond clinical development
4:23pm on Monday 12th of October, 2026 AEDT
•
Biotechnology
Read Story
Mesoblast’s Ryoncil launch opens a new chapter beyond clinical development
4:23pm on Monday 12th of October, 2026 AEDT
Key Points
Ryoncil net product sales reached US$115.2 million
Total revenue rose to US$120.3 million from US$17.2 million
Net operating cash usage fell to US$43.8 million
US$125 million related-party credit facility refinanced existing debt
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Mesoblast (ASX:MSB)
OPEN ARTICLE